Skip to main content

Part of UT Health San Antonio

Graduate School of Biomedical Sciences, UT Health San AntonioGraduate School of Biomedical Sciences, UT Health San Antonio

Part of UT Health San Antonio

Give
Search

Quicklinks

Commencement

  • Commencement 2021

Logins

  • Canvas
  • CourseLeaf
  • IMPACT
  • LiveMail
  • My UT Health (Intranet)

Resources

  • COVID-19 Updates for Students
  • Enrolled Student Resources
  • Educational Resources
  • GSBS Data Request Form

 Close Quicklinks

 
Menu
  • About
  • Admissions
  • Programs
  • Research
  • Faculty
  • Student Life
  • Alumni

You are here

  • Faculty directory
  • Muhammad Abdul-Ghani
Muhammad Abdul-Ghani

Contact

210-557-1157

Abdulghani@uthscsa.edu

Programs

M.D./Ph.D. in South Texas Medical Scientist Training Program
Ph.D. in Integrated Biomedical Sciences
Physiology and Pharmacology

Departments & Divisions

Department of Medicine
Division of Diabetes

Muhammad Abdul-Ghani, M.D., Ph.D.

Professor/Research

Muhammad Abdul-Ghani, MD, PhD is a Professor of Medicine at the Diabetes Division, University of Texas Health Science Center at San Antonio. He graduated from the MD, PhD program of the Hebrew University of Jerusalem. His research interest focuses on the pathophysiology, prevention and treatment of type 2 diabetes. He has published over 160 articles in peer reviewed journal in the field.  

  • Publications

    Triplitt C, Solis-Herrera C, Cersosimo E,Abdul-Ghani M, Defronzo RA. Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus. Expert Opin Pharmacother. 2015 [Epub ahead of print]

    Abdul-Ghani M, DeFronzo RA. The place of renal sodium-glucose co-transport in the management of type 2 diabetes mellitus. Am J Physiol. 2015 (ahead of print).

    Kanat M, DeFronzo RA and Abdul-Ghani M, Treatment of prediabetes. World J Diabetes. 6:1207-22, 2015

    Abdul-Ghani MA, Puckett C, Triplitt C, Maggs D, Adams J, Cersosimo E, DeFronzo RA Initial Combination Therapy with Metformin/Pioglitazone/Exenatide is More Effective Than Sequential Add-On Therapy in Subjects with New Onset Diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): A Randomized Trial. Diabetes Obes Metab. 17:268-75, 2015

    Winnier DA, Fourcaudot M, Norton L, Abdul-Ghani MA, Hu SL, Farook VS, Coletta DK, Kumar S, Puppala S, Chittoor G, Dyer TD, Arya R, Carless M, Lehman DM, Curran JE, Cromack DT, Tripathy D, Blangero J, Duggirala R, Göring HH, DeFronzo RA, Jenkinson CP. Transcriptomic Identification of ADH1B as a Novel Candidate Gene for Obesity and Insulin Resistance in Human Adipose Tissue in Mexican Americans from the Veterans Administration Genetic Epidemiology Study (VAGES).PLoS One. 10:e0119941, 2015

    Valaparla SK; Gao F; Daniele G; Abdul-Ghani M; Clarke GD. Fiber orientation measurements by diffusion tensor imaging improve hydrogen-1 magnetic resonance spectroscopy of intramyocellular lipids in human leg muscles Journal of Medical Imaging 2: 026002, 2015

Map image of UT Health San Antonio location
UT Health San Antonio
Graduate School of Biomedical Sciences

7703 Floyd Curl Drive

San Antonio, TX 78229

210-567-3709

gsbs@uthscsa.edu

  • About us
  • Contact us
  • Maps & directions

We make lives better ®

The University of Texas Health Science Center at San Antonio, also called UT Health San Antonio, is a leading academic health center with a mission to make lives better through excellence in advanced academics, life-saving research and comprehensive clinical care including health, dental and cancer services.

Web Privacy | Links from websites affiliated with UT Health's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.